LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022

Rhea-AI Summary

LENSAR, Inc. (NASDAQ: LNSR) will announce its first quarter 2022 financial results before market open on May 9, 2022. A conference call and webcast will follow at 8:30 am ET, where management will discuss financial outcomes and corporate highlights. LENSAR specializes in advanced femtosecond laser systems for cataract treatment, integrating proprietary technologies aimed at enhancing surgical efficiency and visual outcomes.

Positive

• Upcoming financial results announcement may offer insights into performance metrics.
• Focus on advanced femtosecond laser technology showcases innovation in cataract treatment.

Negative

• None.

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2022 financial results will be released before market open on Monday, May 9, 2022. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Monday, May 9, 2022 to discuss the financial results and recent corporate highlights.

To participate by telephone, please dial (833) 312-1363 (Domestic) or (236) 712-2498 (International). The conference ID number is 3354968. To access the live webcast, please go to the Investors section of LENSAR’s website at www.lensar.com. Following the live webcast, an archived version of the call will be available on the website.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005058/en/

Thomas R. Staab, II, CFO

ir.contact@lensar.com

Lee Roth / Cameron Radinovic

Burns McClellan for LENSAR

lroth@burnsmc.com / cradinovic@burnsmc.com

Source: LENSAR, Inc.

FAQ

When will LENSAR announce its first quarter 2022 financial results?

LENSAR will announce its first quarter 2022 financial results on May 9, 2022.

What time is LENSAR's conference call for Q1 2022 results?

The conference call for LENSAR's Q1 2022 results is scheduled for 8:30 am ET on May 9, 2022.

How can I access LENSAR's Q1 2022 financial results webcast?

You can access the webcast on LENSAR's investor relations section of their website at www.lensar.com.

What is the focus of LENSAR's medical technology?

LENSAR focuses on advanced femtosecond laser surgical solutions for cataract treatment.